File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay
  • Basic View
  • Metadata View
  • XML View
TitleDifferential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay
 
AuthorsYuan, Q2
Cheng, XD1
Yang, BC2
Zheng, QB2
Chen, YX2
Chen, QR2
Zeng, F2
Zhang, R1
Ge, SX2
Hao, XK1
Chen, H3
Zhang, J2
Xia, NS2
 
KeywordsHaemagglutinin
Immunoassay
Influenza A virus
Influenza diagnosis
Pandemic (H1N1) 2009 virus
 
Issue Date2011
 
PublisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CLM
 
CitationClinical Microbiology And Infection, 2011, v. 17 n. 10, p. 1574-1580 [How to Cite?]
DOI: http://dx.doi.org/10.1111/j.1469-0691.2010.03413.x
 
AbstractA sensitive and convenient immunoassay that can directly differentiate pandemic (H1N1) 2009 (pH1N1) virus from seasonal influenza virus can play an important role in the clinic. In the presented study, a double-sandwich ELISA (pH1N1 ELISA), based on two monoclonal antibodies against haemagglutinin (HA) of the pH1N1 virus, was developed. After laboratory determination of the sensitivity and specificity characteristics, the performance of this assay was evaluated in a cohort of 904 patients with influenza-like illness. All seven strains of pH1N1 virus tested were positive by pH1N1 ELISA, with an average lower detection limit of 10 3.0±0.4 tissue culture infective dose (TCID) 50/mL (or 0.009±0.005HA titre). Cross-reaction of the assay with seasonal influenza virus and other common respiratory pathogens was rare. In pH1N1-infected patients, the sensitivity of the pH1N1 ELISA was 92.3% (84/91, 95% CI 84.8-96.9%), which is significantly higher than that of the BD Directigen EZ Flu A+B test (70.3%, p<0.01). The specificity of pH1N1 ELISA in seasonal influenza A patients was 100.0% (171/171, 95% CI 97.9-100.0%), similar to that in non-influenza A patients (640/642, 99.7%, 95% CI 98.9-100.0%). The positive predictive value for pH1N1 ELISA was 97.7% and the negative predictive value was 99.1% in this study population with a pH1N1 prevalence of 10.1%. In conclusion, detection of HA of pH1N1 virus by immunoassay appears to be a convenient and reliable method for the differential diagnosis of pH1N1 from other respiratory pathogens, including seasonal influenza virus. © 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.
 
ISSN1198-743X
2013 Impact Factor: 5.197
2013 SCImago Journal Rankings: 2.280
 
DOIhttp://dx.doi.org/10.1111/j.1469-0691.2010.03413.x
 
ISI Accession Number IDWOS:000295086100023
Funding AgencyGrant Number
Key Special Subjects of Infectious Diseases2008ZX10004-006
Key Project of Science & Technology of Fujian Province2008Y0059
National High Technology Research and Development Program2010AA022801
Funding Information:

This work was supported by grants from Key Special Subjects of Infectious Diseases (2008ZX10004-006), the Key Project of Science & Technology of Fujian Province (2008Y0059) and the National High Technology Research and Development Program (2010AA022801).

 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorYuan, Q
 
dc.contributor.authorCheng, XD
 
dc.contributor.authorYang, BC
 
dc.contributor.authorZheng, QB
 
dc.contributor.authorChen, YX
 
dc.contributor.authorChen, QR
 
dc.contributor.authorZeng, F
 
dc.contributor.authorZhang, R
 
dc.contributor.authorGe, SX
 
dc.contributor.authorHao, XK
 
dc.contributor.authorChen, H
 
dc.contributor.authorZhang, J
 
dc.contributor.authorXia, NS
 
dc.date.accessioned2011-10-28T02:45:38Z
 
dc.date.available2011-10-28T02:45:38Z
 
dc.date.issued2011
 
dc.description.abstractA sensitive and convenient immunoassay that can directly differentiate pandemic (H1N1) 2009 (pH1N1) virus from seasonal influenza virus can play an important role in the clinic. In the presented study, a double-sandwich ELISA (pH1N1 ELISA), based on two monoclonal antibodies against haemagglutinin (HA) of the pH1N1 virus, was developed. After laboratory determination of the sensitivity and specificity characteristics, the performance of this assay was evaluated in a cohort of 904 patients with influenza-like illness. All seven strains of pH1N1 virus tested were positive by pH1N1 ELISA, with an average lower detection limit of 10 3.0±0.4 tissue culture infective dose (TCID) 50/mL (or 0.009±0.005HA titre). Cross-reaction of the assay with seasonal influenza virus and other common respiratory pathogens was rare. In pH1N1-infected patients, the sensitivity of the pH1N1 ELISA was 92.3% (84/91, 95% CI 84.8-96.9%), which is significantly higher than that of the BD Directigen EZ Flu A+B test (70.3%, p<0.01). The specificity of pH1N1 ELISA in seasonal influenza A patients was 100.0% (171/171, 95% CI 97.9-100.0%), similar to that in non-influenza A patients (640/642, 99.7%, 95% CI 98.9-100.0%). The positive predictive value for pH1N1 ELISA was 97.7% and the negative predictive value was 99.1% in this study population with a pH1N1 prevalence of 10.1%. In conclusion, detection of HA of pH1N1 virus by immunoassay appears to be a convenient and reliable method for the differential diagnosis of pH1N1 from other respiratory pathogens, including seasonal influenza virus. © 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.
 
dc.description.naturelink_to_OA_fulltext
 
dc.identifier.citationClinical Microbiology And Infection, 2011, v. 17 n. 10, p. 1574-1580 [How to Cite?]
DOI: http://dx.doi.org/10.1111/j.1469-0691.2010.03413.x
 
dc.identifier.doihttp://dx.doi.org/10.1111/j.1469-0691.2010.03413.x
 
dc.identifier.epage1580
 
dc.identifier.hkuros197236
 
dc.identifier.isiWOS:000295086100023
Funding AgencyGrant Number
Key Special Subjects of Infectious Diseases2008ZX10004-006
Key Project of Science & Technology of Fujian Province2008Y0059
National High Technology Research and Development Program2010AA022801
Funding Information:

This work was supported by grants from Key Special Subjects of Infectious Diseases (2008ZX10004-006), the Key Project of Science & Technology of Fujian Province (2008Y0059) and the National High Technology Research and Development Program (2010AA022801).

 
dc.identifier.issn1198-743X
2013 Impact Factor: 5.197
2013 SCImago Journal Rankings: 2.280
 
dc.identifier.issue10
 
dc.identifier.pmid21054661
 
dc.identifier.scopuseid_2-s2.0-79959740973
 
dc.identifier.spage1574
 
dc.identifier.urihttp://hdl.handle.net/10722/142420
 
dc.identifier.volume17
 
dc.languageeng
 
dc.publisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CLM
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofClinical Microbiology and Infection
 
dc.relation.referencesReferences in Scopus
 
dc.rightsThe definitive version is available at www.blackwell-synergy.com
 
dc.subject.meshAntibodies, Viral - immunology
 
dc.subject.meshHemagglutinin Glycoproteins, Influenza Virus - diagnostic use - immunology
 
dc.subject.meshInfluenza A Virus, H1N1 Subtype - immunology - pathogenicity
 
dc.subject.meshInfluenza, Human - diagnosis - epidemiology - immunology - virology
 
dc.subject.meshPandemics
 
dc.subjectHaemagglutinin
 
dc.subjectImmunoassay
 
dc.subjectInfluenza A virus
 
dc.subjectInfluenza diagnosis
 
dc.subjectPandemic (H1N1) 2009 virus
 
dc.titleDifferential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Yuan, Q</contributor.author>
<contributor.author>Cheng, XD</contributor.author>
<contributor.author>Yang, BC</contributor.author>
<contributor.author>Zheng, QB</contributor.author>
<contributor.author>Chen, YX</contributor.author>
<contributor.author>Chen, QR</contributor.author>
<contributor.author>Zeng, F</contributor.author>
<contributor.author>Zhang, R</contributor.author>
<contributor.author>Ge, SX</contributor.author>
<contributor.author>Hao, XK</contributor.author>
<contributor.author>Chen, H</contributor.author>
<contributor.author>Zhang, J</contributor.author>
<contributor.author>Xia, NS</contributor.author>
<date.accessioned>2011-10-28T02:45:38Z</date.accessioned>
<date.available>2011-10-28T02:45:38Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>Clinical Microbiology And Infection, 2011, v. 17 n. 10, p. 1574-1580</identifier.citation>
<identifier.issn>1198-743X</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/142420</identifier.uri>
<description.abstract>A sensitive and convenient immunoassay that can directly differentiate pandemic (H1N1) 2009 (pH1N1) virus from seasonal influenza virus can play an important role in the clinic. In the presented study, a double-sandwich ELISA (pH1N1 ELISA), based on two monoclonal antibodies against haemagglutinin (HA) of the pH1N1 virus, was developed. After laboratory determination of the sensitivity and specificity characteristics, the performance of this assay was evaluated in a cohort of 904 patients with influenza-like illness. All seven strains of pH1N1 virus tested were positive by pH1N1 ELISA, with an average lower detection limit of 10 3.0&#177;0.4 tissue culture infective dose (TCID) 50/mL (or 0.009&#177;0.005HA titre). Cross-reaction of the assay with seasonal influenza virus and other common respiratory pathogens was rare. In pH1N1-infected patients, the sensitivity of the pH1N1 ELISA was 92.3% (84/91, 95% CI 84.8-96.9%), which is significantly higher than that of the BD Directigen EZ Flu A+B test (70.3%, p&lt;0.01). The specificity of pH1N1 ELISA in seasonal influenza A patients was 100.0% (171/171, 95% CI 97.9-100.0%), similar to that in non-influenza A patients (640/642, 99.7%, 95% CI 98.9-100.0%). The positive predictive value for pH1N1 ELISA was 97.7% and the negative predictive value was 99.1% in this study population with a pH1N1 prevalence of 10.1%. In conclusion, detection of HA of pH1N1 virus by immunoassay appears to be a convenient and reliable method for the differential diagnosis of pH1N1 from other respiratory pathogens, including seasonal influenza virus. &#169; 2011 The Authors. Clinical Microbiology and Infection &#169; 2011 European Society of Clinical Microbiology and Infectious Diseases.</description.abstract>
<language>eng</language>
<publisher>Blackwell Publishing Ltd. The Journal&apos;s web site is located at http://www.blackwellpublishing.com/journals/CLM</publisher>
<relation.ispartof>Clinical Microbiology and Infection</relation.ispartof>
<rights>The definitive version is available at www.blackwell-synergy.com</rights>
<subject>Haemagglutinin</subject>
<subject>Immunoassay</subject>
<subject>Influenza A virus</subject>
<subject>Influenza diagnosis</subject>
<subject>Pandemic (H1N1) 2009 virus</subject>
<subject.mesh>Antibodies, Viral - immunology</subject.mesh>
<subject.mesh>Hemagglutinin Glycoproteins, Influenza Virus - diagnostic use - immunology</subject.mesh>
<subject.mesh>Influenza A Virus, H1N1 Subtype - immunology - pathogenicity</subject.mesh>
<subject.mesh>Influenza, Human - diagnosis - epidemiology - immunology - virology</subject.mesh>
<subject.mesh>Pandemics</subject.mesh>
<title>Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay</title>
<type>Article</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.doi>10.1111/j.1469-0691.2010.03413.x</identifier.doi>
<identifier.pmid>21054661</identifier.pmid>
<identifier.scopus>eid_2-s2.0-79959740973</identifier.scopus>
<identifier.hkuros>197236</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-79959740973&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>17</identifier.volume>
<identifier.issue>10</identifier.issue>
<identifier.spage>1574</identifier.spage>
<identifier.epage>1580</identifier.epage>
<identifier.isi>WOS:000295086100023</identifier.isi>
<publisher.place>United Kingdom</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/142420/1/re01.htm</bitstream.url>
</item>
Author Affiliations
  1. Xijing Hospital
  2. Xiamen University
  3. The University of Hong Kong